Home/Filings/4/0000899243-20-034283
4//SEC Filing

Angelino Mark D. 4

Accession 0000899243-20-034283

CIK 0001733294other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:05 PM ET

Size

12.2 KB

Accession

0000899243-20-034283

Insider Transaction Report

Form 4
Period: 2020-12-15
Angelino Mark D.
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2020-12-155,301118,460 total
    Exercise: $4.59Exp: 2028-04-01Common Stock (5,301 underlying)
  • Exercise/Conversion

    Common Stock

    2020-12-15$4.59/sh+5,301$24,332350,938 total
  • Sale

    Common Stock

    2020-12-15$34.87/sh4,401$153,463346,537 total
  • Sale

    Common Stock

    2020-12-15$35.52/sh900$31,968345,637 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    169,846
Footnotes (5)
  • [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2020.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.39 to $35.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.41 to $35.84, inclusive.
  • [F4]The securities are directly held by the Mark D. Angelino 2020 Qualified Annuity Trust, or the Trust. Mark D. Angelino is the settlor and trustee of the Trust, and the Trust is for the benefit of Elizabeth I., Emily A., John P., and Matthew R. Angelino. The reporting person may be deemed to beneficially own the shares of common stock owned by the Trust.
  • [F5]The option to purchase 123,761 shares was granted on April 2, 2018. The shares underlying the option vest over four years, with 25% of the shares vested on April 2, 2019 and the remaining shares vesting in equal quarterly installments thereafter.

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0001814308

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:05 PM ET
Size
12.2 KB